Startups
Startups are the Lifeblood of the Economy
In countries across the world, startups are responsible for creating jobs, driving innovation, and stimulating economic growth. They are the lifeblood of the economy. Carl
December 7, 2022
Carl Iberger
Business Consultant - Hingham, MA
Currently, Carl Iberger is the manager of the consulting company Wright Leeds, LLC. Carl’s role in this business is to help entrepreneurs in the health sector to develop their business. He helped many CEOs to follow up on their mission statement, and partner with management at the senior level to focus on core strategies, and build cross -departmental workflows to improve efficiency and output, and make companies more successful.
With more than 35 years of accounting, financial and management experience, Mr. Career Iberger is one of the four founders who built a startup company into a $ 100 million diagnostic company. Mr. Iberger has held the CFO responsibility for and managing accounting, finance, contracts, employee benefits, reimbursement, and IT organizations. Partnering with the CEO, its success includes two public offerings and two successful private company transfers to industrial competitors.
The career of Mr. Iberger includes success in CEO partnerships that includes companies starting from the ground up to late-stage private companies through to public offerings and entity sales. Guiding healthcare startups through the initial, medium and final stages, Mr. Iberger has an in-depth experience in a high stress environment, accelerated growth, multi-site multi-country operations, and M&A activities.
Mr. Iberger has served as Chief Financial Officer from 2016 to April 2022 for cancer diagnostic and genetic technology companies that provide liquid biopsy testing to office based oncology laboratory tests to the commercial oncology diagnostic markets. The company completed their Merger Reverse Pubic in 2017.
Before serving as a CFO to a genetic technology company, Mr. Iberger held a role as a Chief Financial Officer from 2000 to 2010 from a pulmonology/neurology diagnostic company valued at $100 million and from 2010 to 2015 he served as Vice President of the Executive Therapy Division. The company was sold to private equity in 2012.
From 1996 to 2000, Mr. Iberger served as Chief Financial Officer for neurological diagnostic companies and carried out successful sales and exit for initial investors to industrial competitors in 2000.
From 1986 to 1996, Mr. Iberger served as Vice President of Finance & Administration and Controller for a diagnostic company who specializes in cancer research. Partnering with the CEO of the company executed a successful public offering in 1990.
Mr. Iberger holds a master’s degree in finance from Hofstra University and a bachelor’s degree in accounting from the University of Connecticut.
